Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year debt growth rate
Latest
-5.12%
↓ 101% vs avg
Percentile
P36
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
634.12%
Historical baseline
| Period | Value |
|---|---|
| Q1 2026 | -5.12% |
| Q4 2025 | -8.37% |
| Q3 2025 | -5.81% |
| Q2 2025 | -5.16% |
| Q1 2025 | -4.99% |
| Q4 2024 | -4.67% |
| Q3 2024 | -4.35% |
| Q2 2024 | -4.03% |
| Q1 2024 | -3.83% |
| Q4 2023 | -3.60% |
| Q3 2023 | -2.88% |
| Q2 2023 | -3.03% |
| Q1 2023 | -1.08% |
| Q4 2022 | -2.83% |
| Q3 2022 | -2.54% |
| Q2 2022 | -1.72% |
| Q1 2022 | 1.87% |
| Q4 2021 | -0.54% |
| Q3 2021 | -0.99% |
| Q2 2021 | 49.41% |
| Q1 2021 | -1.97% |
| Q4 2020 | -1.15% |
| Q3 2020 | 74.59% |
| Q2 2020 | -4.28% |
| Q1 2020 | 1.54% |
| Q4 2019 | -2.76% |
| Q3 2019 | 25018.75% |
| Q2 2019 | -92.86% |
| Q1 2019 | -5.49% |
| Q4 2018 | -16.84% |
| Q3 2018 | 562.79% |
| Q2 2018 | -12.24% |
| Q1 2018 | -10.91% |
| Q4 2017 | -5.17% |
| Q3 2017 | 0.00% |
| Q2 2017 | -100.00% |
| Q1 2017 | -6.85% |
| Q4 2016 | -6.41% |
| Q3 2016 | -6.02% |
| Q2 2016 | -5.68% |